Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32466
CAS Number:
6190-39-2
Sel de méthanesulfonate de dihydroergotamine
Purity:
≥ 99 % (HPLC)
Synonym(s):
Mésylate de dihydroergotamine
Documents
$88.63 /100 mg
Taille
Request Bulk Quote
Product Information

Agoniste des récepteurs vasculaires de la sérotonine ; agoniste partiel des récepteurs alpha-adrénergiques et dopaminergiques D2 ! Conserver le récipient hermétiquement fermé dans un endroit sec et bien ventilé.

Synonyms
Mésylate de dihydroergotamine
CAS Number
6190-39-2
Purity
≥ 99 % (HPLC)
Molecular Formula
C33H37N5O5 · CH4O3S
Molecular Weight
679.78
MDL Number
MFCD00058615
PubChem ID
517557
Melting Point
230 - 235 ?C
Appearance
Poudre blanche à jaune clair à rouge clair ou cristal
Optical Rotation
[a] D 20 = -17 à -23 ° (C = 0,25, méthode JP) (calculé sur substance séchée)
Conditions
Magasin chez RT
General Information
Synonyms
Mésylate de dihydroergotamine
CAS Number
6190-39-2
Purity
≥ 99 % (HPLC)
Molecular Formula
C33H37N5O5 · CH4O3S
Molecular Weight
679.78
MDL Number
MFCD00058615
PubChem ID
517557
Melting Point
230 - 235 ?C
Appearance
Poudre blanche à jaune clair à rouge clair ou cristal
Optical Rotation
[a] D 20 = -17 à -23 ° (C = 0,25, méthode JP) (calculé sur substance séchée)
Conditions
Magasin chez RT
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Dihydroergotamine methanesulfonate salt is widely utilized in research focused on:

  • Migraine Treatment: This compound is primarily used in the medical field to treat acute migraine attacks. It works by constricting blood vessels in the brain, providing relief to patients who suffer from severe headaches.
  • Vascular Research: In pharmacological studies, it serves as a model compound for understanding vascular responses. Researchers can explore its effects on blood flow and vascular tone, aiding in the development of new cardiovascular therapies.
  • Pharmaceutical Development: The compound is often used in the formulation of medications, allowing scientists to study its stability and efficacy in various delivery systems, such as intranasal or injectable forms.
  • Neuropharmacology: It is utilized in neuropharmacological research to investigate its interactions with serotonin receptors, contributing to the understanding of neurotransmitter systems and potential treatments for other neurological disorders.
  • Clinical Trials: Dihydroergotamine methanesulfonate salt is frequently involved in clinical trials aimed at assessing new therapeutic strategies for migraine and other headache disorders, providing valuable data for future drug approvals.

Citations